Lower prescription drug costs predicted for 2018

The increase in prescription drug benefit cost trends will be lower in 2018 than in 2017, according to the 2018 Segal Health Plan Cost Trend Survey. The survey found that outpatient prescription coverage for active employees and retirees under age 65 will be 10.3 percent in 2018, down from 11.6 percent in 2017. And, the projected increase for specialty drugs/biologics also is projected to decrease in 2018, from 18.7 percent down to 17.7 percent.
The survey also found the following:

  • Medical plan cost trend increases are projected to be slightly higher than 2017 projections.
  • Price inflation—not utilization—is the leading driver of trend.
  • Prescription drug cost-management strategies and improved vendor contracting are plan sponsors’ top priorities.

“Health plan cost increases continue to significantly outpace general inflation and average wage increases, underscoring the need to monitor performance targeting cost-management efforts,” said Edward Kaplan, Segal’s National Health Practice Leader. “Plan sponsors can use the survey results to support their 2018 rate renewal negotiations and their budget projections.”

Price inflation.

Segal found that as was the case in last year’s survey, the leading driver of trend increases for 2018 continues to be price inflation for physician services, hospital services and prescription drugs. For prescription drugs, it is nearly 9 percent. “While patients may not be getting more procedures done, some of the price inflation is due to inappropriate use of emergency rooms and urgent-care facilities and unnecessary, expensive diagnostic radiology procedures when a simple x-ray would suffice,” said Eileen Flick, senior vice president and Director of Health Technical Services at Segal. “Plan sponsors should ensure their plan designs are properly aligned with the costs of care, and that their participants are making smart choices in order to get the right care at the right price with the right provider.”

Cost management strategies.

Segal asked the survey participants to rank the cost-management strategies implemented by group health plans in 2017. The survey found that the top five strategies are:

1. Using specialty pharmacy management;
2. Intensifying pharmacy management programs;
3. Contracting with value-based providers;
4. Increasing financial incentives in wellness design; and
5. Adopting a high deductible health plan (HDHP).

These strategies show plan sponsors are looking to drive utilization to high quality, low cost providers in lieu of simply passing the costs on to their employees. Plan sponsors continue to embrace a wide range of strategies to lower costs, including the use of custom and limited provider networks, expansion of dedicated primary care clinics that are on or near work-sites and, for some industries, continued migration to tax advantaged Health Savings Accounts and HDHPs.
“Each plan sponsor has a unique set of goals, but all share in the common objective of managing cost increases,” added Kaplan. “In that sense, we highly recommend a three-pronged approach to the challenge of health care cost management that encompasses vendor management, plan design management and population health management.”

SOURCE: www.segalco.com
Visit our News Library to read more news stories.